CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.53−0.07 (-11.77%)
Close on Nov 19, 2026Market cap $14.20MP/E –Yield –
CVRx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
CVRx's free cash flow for the twelve months ending Jun 30, 2026 was -$41.05M. For fiscal 2025 it was -$40.75M. The highest annual figure on record is -$16.41M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$40.75M | – |
| FY2024 | Dec 31, 2024 | -$40.51M | – |
| FY2023 | Dec 31, 2023 | -$39.61M | – |
| FY2022 | Dec 31, 2022 | -$43.36M | – |
| FY2021 | Dec 31, 2021 | -$28.92M | – |
| FY2020 | Dec 31, 2020 | -$16.41M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.94M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.29M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.00M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.81M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.01M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.95M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.92M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.15M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.94M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.55M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.14M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.28M | – |
See a number that looks wrong?